|
Mutation Information
|
Mutation Site
|
G646C |
|
Mutation Type
|
Nucleotide level |
|
Gene/Protein/Region Type
|
RT |
|
Combined Mutation
|
rt.V173L+rt.M204V+rt.L180M |
|
Nucleotide_Mutation
|
V173L |
|
Genotype/Subtype
|
C |
|
Relevant Drug
|
lamivudine (LAM) |
Literature Information
|
PubMed PMID
|
18713056
|
|
Disease
|
HBV infection
|
|
Published Year
|
2008 |
|
Journal
|
The Journal of infectious diseases |
|
Title
|
Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus. |
|
Author
|
Ohkawa K,Takehara T,Kato M,Deguchi M,Kagita M,Hikita H,Sasakawa A,Kohga K,Uemura A,Sakamori R,Yamaguchi S,Miyagi T,Ishida H,Tatsumi T,Hayashi N |
|
Evidence
|
The T/C646 mutation, which causes the rtV173L change, was detected in 5 strains (31%) with rtM204V, compared with none of those with rtM204I (P < .005).
|
|
|
HBV Mutation Detail Information